Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy

Exclusion Criteria

• •Experienced serious adverse event during the A0081066 trial that was considered related or possibly related to study medication by the investigator or sponsor
• •non-compliant during A0081066 trial
• •clinically significant or unstable medical condition both HIV-related and non-HIV related including but not limited to, cardiac, pulmonary or hepatorenal disease that, in the opinion of the investigator, would compromise participation in the study